Jane Street
AUTL

Jane Street’s Autolus Therapeutics AUTL Stock Holding History

Jane Street’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233K Buy
+168,500
New +$256K ﹤0.01% 9798
2025
Q4 		– Sell
-12,600
Closed -$20.5K – 11084
2025
Q3 		$20.5K Buy
+12,600
New +$24.6K ﹤0.01% 10530
2024
Q1 		– Sell
-77,300
Closed -$498K – 9153
2023
Q4 		$498K Buy
+77,300
New +$295K ﹤0.01% 6759

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's AUTL Position: Q1 2026 in Review

Jane Street reduced its Autolus Therapeutics (AUTL) stake by 64% in Q1 2026, selling an estimated $661K and leaving 245,785 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #8956.

Jane Street first reported a position in AUTL in Q2 2020 and has held it in 16 quarters since. The position peaked at $1.43M in Q3 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

  • Jane Street held 245,785 shares of Autolus Therapeutics worth $339K as of Q1 2026.
  • Jane Street sold 435,215 Autolus Therapeutics shares in Q1 2026, an estimated $661K.
  • Autolus Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8956 holding.
  • Jane Street first reported a position in Autolus Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • Jane Street's Autolus Therapeutics position peaked at $1.43M in Q3 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.